These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27016342)

  • 1. Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.
    Ramani VC; Vlodavsky I; Ng M; Zhang Y; Barbieri P; Noseda A; Sanderson RD
    Matrix Biol; 2016 Sep; 55():22-34. PubMed ID: 27016342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.
    Bandari SK; Purushothaman A; Ramani VC; Brinkley GJ; Chandrashekar DS; Varambally S; Mobley JA; Zhang Y; Brown EE; Vlodavsky I; Sanderson RD
    Matrix Biol; 2018 Jan; 65():104-118. PubMed ID: 28888912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.
    Ramani VC; Zhan F; He J; Barbieri P; Noseda A; Tricot G; Sanderson RD
    Oncotarget; 2016 Jan; 7(2):1598-607. PubMed ID: 26624982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity.
    Ramani VC; Yang Y; Ren Y; Nan L; Sanderson RD
    J Biol Chem; 2011 Feb; 286(8):6490-9. PubMed ID: 21131364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase promotes myeloma stemness and in vivo tumorigenesis.
    Tripathi K; Ramani VC; Bandari SK; Amin R; Brown EE; Ritchie JP; Stewart MD; Sanderson RD
    Matrix Biol; 2020 Jun; 88():53-68. PubMed ID: 31812535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype.
    Purushothaman A; Hurst DR; Pisano C; Mizumoto S; Sugahara K; Sanderson RD
    J Biol Chem; 2011 Sep; 286(35):30377-30383. PubMed ID: 21757697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.
    Purushothaman A; Chen L; Yang Y; Sanderson RD
    J Biol Chem; 2008 Nov; 283(47):32628-36. PubMed ID: 18812315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    Xiang J; Lu M; Shi M; Cheng X; Kwakwa KA; Davis JL; Su X; Bakewell SJ; Zhang Y; Fontana F; Xu Y; Veis DJ; DiPersio JF; Ratner L; Sanderson RD; Noseda A; Mollah S; Li J; Weilbaecher KN
    J Virol; 2022 Apr; 96(7):e0005722. PubMed ID: 35319225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase enhances the insulin receptor signaling pathway to activate extracellular signal-regulated kinase in multiple myeloma.
    Purushothaman A; Babitz SK; Sanderson RD
    J Biol Chem; 2012 Nov; 287(49):41288-96. PubMed ID: 23048032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual enhancement between heparanase and vascular endothelial growth factor: a novel mechanism for melanoma progression.
    Luan Q; Sun J; Li C; Zhang G; Lv Y; Wang G; Li C; Ma C; Gao T
    Cancer Lett; 2011 Sep; 308(1):100-11. PubMed ID: 21624769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined TRAF6 Targeting and Proteasome Blockade Has Anti-myeloma and Anti-Bone Resorptive Effects.
    Chen H; Li M; Sanchez E; Wang CS; Lee T; Soof CM; Casas CE; Cao J; Xie C; Udd KA; DeCorso K; Tang GY; Spektor TM; Berenson JR
    Mol Cancer Res; 2017 May; 15(5):598-609. PubMed ID: 28122920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth.
    Bhattacharya U; Gutter-Kapon L; Kan T; Boyango I; Barash U; Yang SM; Liu J; Gross-Cohen M; Sanderson RD; Shaked Y; Ilan N; Vlodavsky I
    Cancer Res; 2020 Jan; 80(1):57-68. PubMed ID: 31690669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.
    Ritchie JP; Ramani VC; Ren Y; Naggi A; Torri G; Casu B; Penco S; Pisano C; Carminati P; Tortoreto M; Zunino F; Vlodavsky I; Sanderson RD; Yang Y
    Clin Cancer Res; 2011 Mar; 17(6):1382-93. PubMed ID: 21257720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of eukaryotic initiation factor-4E (eIF-4E) in regulation of expression of NF-kappaB and its subsequent influence on transcription and activity of heparanase in human colon adenocarcinoma cell line].
    Yang YJ; Zhang YL; Wang JD; Lai ZS; Wang QY; Cui HH
    Ai Zheng; 2003 Oct; 22(10):1023-9. PubMed ID: 14558943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
    Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
    Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Heparanase Regulates Chromatin Remodeling, Gene Expression and PTEN Tumor Suppressor Function.
    Amin R; Tripathi K; Sanderson RD
    Cells; 2020 Sep; 9(9):. PubMed ID: 32899927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
    Ilan N; Elkin M; Vlodavsky I
    Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
    Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
    Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.